Sat.Jun 24, 2023 - Fri.Jun 30, 2023

article thumbnail

10 clinical trials to watch in the second half of 2023

BioPharma Dive

A Duchenne gene therapy faces a crucial test, while highly anticipated study results are expected in lung cancer, obesity and heart disease.

114
114
article thumbnail

How can real-world evidence support regulatory decision making?

European Pharmaceutical Review

The European Medicines Agency (EMA) has published its report: Real-world evidence framework (RWE) to support EU regulatory decision-making. The review summarised what the organisation has learned from conducting real-world data (RWD) regulator-led studies from September 2021 to February 2023. There were 61 RWD research opportunities identified, 30 studies initiated and 27 completed in this period.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Optimizing Patient Care Services with Rare Disease Limited Distribution Drugs

Orsini Pharmacy

The complexities of managing the care of a rare disease patient are tremendous. Several models of care are efficient when optimizing patient care services with rare disease limited distribution drugs; however, the most promising is the concierge model. This model is where all communications would filter through the health plan. The health plan has a line of sight to precisely what that patient needs and where to get their drug.

article thumbnail

Transgender patients are rarely included in clinical trials. Can pharma fix it?

PharmaVoice

Transgender and nonbinary patients suffer more adverse health outcomes than the general population, yet are often underrepresented in clinical research. Now, there’s momentum to change the status quo.

236
236
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

BioMarin finally secures FDA approval of hemophilia gene therapy

BioPharma Dive

After a prolonged journey, the medicine, known as Roctavian, is now cleared for certain patients with hemophilia A, the more common form of the rare bleeding disorder.

133
133

More Trending

article thumbnail

Vertex and Lonza to establish T1D cell therapy manufacturing facility

Pharmaceutical Technology

Vertex and Lonza have entered a partnership to establish a facility in Portsmouth, US, to manufacture cell therapies for type 1 diabetes.

article thumbnail

US FDA grants fast track status for GSK’s gonorrhoea vaccine

Pharmaceutical Technology

GSK has received a Fast Track designation for its Neisseria gonorrhoeae investigational vaccine from the US Food and Drug Administration.

article thumbnail

Microbiome therapies: a maturing movement

European Pharmaceutical Review

Riding on the momentum of the first faecal microbiota product approved for C. difficile in December 2022, the microbiome therapies space in 2023 has continued to see revolutionary developments and continued research advancement. Recent developments in microbiome therapeutics In May this year, first-in-human study interim results revealed that a CRISPR-based microbial gene therapy can “eliminate antibiotic-resistant E. coli strains in the gut”.

article thumbnail

STAT+: Grail faces uphill battle to get Medicare to cover its cancer screening test

STAT

WASHINGTON — Grail is aggressively lobbying to get Medicare to pay for its cancer-screening test Galleri — but experts tell STAT that the company has a far more complicated path to that end than the makers of most medicines or medical devices. Grail’s controversial blood test Galleri screens for multiple cancers. The Food and Drug Administration has not yet approved it, so Medicare hasn’t had to make a decision on whether to cover it or not.

363
363
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

A pharma summer — how leaders unwind and recharge their teams in the warmer months

PharmaVoice

Vacation is calling, but so are patients. Here's how the industry adjusts in the summer.

255
255
article thumbnail

Pursuing a Career in Pharmacy: Empowering LGBTQIA+ Students through Advocacy and Diversity

Pharmacy Is Right For Me

Join us as we explore the inspiring journey of Cayden Miller, a passionate pharmacy graduate from Southern Illinois University at Edwardsville School of Pharmacy. Cayden’s experience as a member of the LGBTQIA+ community has shaped his path in pharmacy, driving him to become an advocate for diversity, equity, and inclusion (DEI) within the profession.

246
246
article thumbnail

Genfit and Ipsen announce elafibranor results

Pharma Times

ELATIVE, a randomised PBC trial involving 161 patients, has successfully met its primary endpoint - News - PharmaTimes

136
136
article thumbnail

STAT+: Illumina to lay off 10% of research and development team in bid to cut costs by $100 million

STAT

SAN DIEGO — Months after announcing plans to cut costs by $100 million, DNA sequencing giant Illumina has begun to lay off 10% of its research and development team, according to internal emails obtained and reviewed by STAT. The layoffs, which began last Wednesday, impact research teams across the company’s California sites in San Diego and Foster City, as well as locations in Madison, Wisconsin; Singapore; and the United Kingdom.

349
349
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Major clinical trial trends transforming life sciences research

PharmaVoice

From AI to diversity and decentralized trials, here’s how clinical trial operations are evolving.

246
246
article thumbnail

NASH drugs race to cross the finish line

Pharmaceutical Technology

After Intercept’s Ocaliva rejection, multiple companies are taking aim at becoming the first US-approved NASH therapy.

128
128
article thumbnail

Positive results for Evgen’s rhabdomyosarcoma therapy

Pharma Times

Update on radiosensitising impact of SFX-01 when treating common soft tissue sarcoma condition - News - PharmaTimes

136
136
article thumbnail

ADA says all diabetes patients should be screened for nonalcoholic fatty liver disease

STAT

SAN DIEGO — The American Diabetes Association said Sunday that all adults with type 2 diabetes or prediabetes should be screened for nonalcoholic fatty liver disease, an increasingly prevalent condition that can lead to serious liver damage. There are no approved medications for the disease, but among available diabetes drugs, the ADA singled out GLP-1 treatments as an option doctors could consider, according to recommendations published during the annual ADA conference.

Diabetes 349
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

A unique study on COVID shows how machine learning can help personalize medicine

PharmaVoice

Based on real-world data from patients in China, researchers were able to pinpoint factors that led to recurring infections — and which drug combos helped.

147
147
article thumbnail

FDA approves first cell therapy for type 1 diabetes

pharmaphorum

FDA approves first cell therapy for type 1 diabetes Phil.

Diabetes 122
article thumbnail

MinervaX reveals completion of vaccine trial enrolment

Pharma Times

The company is seeking to address the worldwide impact of group B streptococcus in older adults - News - PharmaTimes

Vaccines 135
article thumbnail

Malaria cases in Florida and Texas: Here’s what you need to know

STAT

The five cases of malaria diagnosed in Florida and Texas in recent weeks — the first cases of local transmission in the United States in 20 years — have worried some residents and led state and federal officials to issue public alerts about the cluster of infections. But scientists and public health officials, while advising people in the affected areas to take precautions, say there is little cause for alarm, for several reasons: The number of cases is very low; there are easy, lo

322
322
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Pharma is still figuring out how to make DEI work. Here are some of the strategies companies are trying

PharmaVoice

Although DEI efforts have ramped up, the industry is still searching for proven ways to get results.

130
130
article thumbnail

Shionogi agrees $140m deal to buy antibiotic biotech Qpex

pharmaphorum

Shionogi agrees $140m deal to buy antibiotic biotech Qpex Phil.

122
122
article thumbnail

Momentum for Poolbeg and CytoReason’s AI collaboration

Pharma Times

Partnership establishes several influenza therapy targets using artificial intelligence - News - PharmaTimes

130
130
article thumbnail

Medical leaders decry Supreme Court decision on affirmative action

STAT

Medical leaders on Thursday reacted swiftly to the Supreme Court’s decision to severely restrict the use of race in college admissions, saying the ruling could reverse decades of progress toward diversifying the nation’s physician workforce — something seen as key to helping end the country’s widespread and deeply entrenched health disparities.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.